Arecor Therapeutics plc (LON:AREC – Get Free Report)’s share price reached a new 52-week low on Friday . The company traded as low as GBX 90 ($1.16) and last traded at GBX 90 ($1.16), with a volume of 25515 shares trading hands. The stock had previously closed at GBX 92.50 ($1.19).
Arecor Therapeutics Stock Down 2.7 %
The firm’s 50 day simple moving average is GBX 120.60 and its 200-day simple moving average is GBX 137.10. The company has a current ratio of 2.17, a quick ratio of 6.24 and a debt-to-equity ratio of 3.55. The stock has a market capitalization of £27.57 million, a price-to-earnings ratio of -506.65 and a beta of -0.21.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Recommended Stories
- Five stocks we like better than Arecor Therapeutics
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Should You Invest in Bitcoin? Pros and Cons
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- What Are the U.K. Market Holidays? How to Invest and Trade
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
